Gabriel de Alba

Richtree Market Restaurants, Inc. owns and operates restaurants. It operates Mediterranean market-style restaurants. Its restaurants are located in Toronto, North York, Mississauga, and Ottawa. The company is headquartered in Toronto, Canada.

Natural Market Restaurants Corp. develops microwave recycling technology. A restaurant and a market serving Mediterranean dishes to take out. Several locations. The company is headquartered in Toronto, Canada.

Sonar Entertainment, Inc. develops, produces, finances and distributes premium content for global audiences. It offers a platform for creative talent with the support of a full-service studio and global distribution company. The company provides new long-form television content, including domestic made-for-television, movies and mini-series. Sonar Entertainment was founded on August 24, 2007 and is headquartered in New York, US.

Cable Satisfaction International, Inc. builds and operates large bandwith (750 Mhz) hybrid fibre coaxial (HFC) networks and through its subsidiary it provides cable television services, high-speed Internet access, telephony and high-speed data transmission services to homes and businesses in Portugal. The company is headquartered in Longueuil, Canada.

Advantage Opco LLC provides car rental services. It offers mini-vans, SUV's, convertibles, and sedans. The company was founded by Kenneth Walker and Helen Walker in 1963 and is headquartered in Orlando, FL.

Cirque du Soleil, Inc. operates as a theatrical entertainment company. The firm creates and produces shows, events, and special projects; and provides creative content for various projects. The company was founded by Guy Lalibert? in 1984 and is headquartered in Montreal, Canada.

Evolve Biologics, Inc. is a Canadian plasma-derived therapeutics company headquartered in Mississauga, CA. The company is focused on commercializing a portfolio of product candidates, including intravenous immunoglobulin (IVIG) and human serum albumin (HSA), both of which are in advanced stages of regulatory approval with the FDA and Health Canada. Evolve's state-of-the-art facility is the first to use its innovative and proprietary technology, Plasmacap EBA®, to commercially produce plasma-derived therapeutics. The company has recently appointed James V. Caggiano as CEO, who brings nearly 30 years of experience in the biotech, pharma, and medical device industries.